Related Experiment Video
Updated: Aug 6, 2026

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
Published on: December 5, 2017
A Rare Case Report-an Early-Stage Invasive Lobular Carcinoma with Her 2 Neu Positivity
Preeti Grewal1, Geeta Kadayaprath2, Parul Sobti3
1Breast Surgical Oncology, Indraprastha Apollo Hospitals, New Delhi, India.
Abstract:
Invasive lobular breast cancer is a rare and special subtype of breast cancer which has a different clinical behaviour and is morphologically different from other subtypes. However, it is not any different in terms of outcome as compared to invasive ductal carcinoma. It accounts for 5-15% of the invasive breast cancers (Li et al. in Br J Cancer 93:1046-1052, 2005). Her 2 Neu positivity in invasive lobular cancers (ILCs) is even rarer and has been linked to adverse outcomes, although limited literature is available. Management of ILCs with Her 2 Neu positivity is according to standard multimodality breast cancer management guidelines. Here, we report a case report of an early-stage invasive lobular breast cancer with hormone receptor and Her 2 Neu positivity.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Mechanisms of Retrovirus-induced Cancers
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Cancers Originate from Somatic Mutations in a Single Cell
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

